Cargando…
Biglycan as a potential diagnostic and prognostic biomarker in multiple human cancers
Biglycan (BGN), a key member of the small leucine-rich proteoglycan family, is an important component of the extracellular matrix. Clinical studies have demonstrated that upregulation of BGN is associated with poor prognosis in patients with various types of solid cancer. The present study analyzed...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039163/ https://www.ncbi.nlm.nih.gov/pubmed/32194659 http://dx.doi.org/10.3892/ol.2020.11266 |